Nephrotic proteinuria has No net effect on total body protein synthesis: measurements with (13)C valine.
In nephrotic syndrome, significant amounts of plasma proteins, mostly of hepatic origin, are lost in urine. Total hepatic protein synthesis increases, suggesting that other protein pools must be conserved to maintain steady state. This can be accomplished either by decreased amino acid oxidation or decreased protein synthesis in other organs to replace lost liver-derived proteins. To determine the effect of nephrotic syndrome on total-body protein metabolism, we compared whole-body valine use in seven nephrotic patients and five controls using a primed continuous infusion of [1-(13)C]-valine, with additional priming of NaH(13)CO(3). Plasma [(13)C]-valine, (13)C alpha ketoisovaleric acid, and the expired (13)CO(2) enrichments were used to assess whole-body valine flux, valine oxidation, and nonoxidative valine disposal (NOVD). The valine flux into the blood compartment (97.7 +/- 3.0 versus 95.3 +/- 3.3 micromol/kg/h), oxidation of valine (19.4 +/- 1.9 versus 21.2 +/- 2. 8 micromol/kg/h), and NOVD (78.3 +/- 2.5 versus 74.2 +/- 2.7 micromol/kg/h) were not statistically different in patients compared with controls. Valine oxidation correlated positively with urinary urea excretion (r = 0.70; P = 0.01) in all subjects. Compared with control subjects who have similar urinary urea excretion, nephrotic subjects do not compensate for urinary loss of protein by decreased amino acid oxidation or decreased nonoxidative valine disposal. Previous studies have shown that synthesis of several hepatic proteins increases when subjects are fed the same dietary regime, whereas the present study shows that total-body protein synthesis does not increase. This would imply reduced synthesis of nonhepatic protein pools.
de Sain-Van Der Velden
M G
MG
Departments of Metabolic Diseases, Nephrology and Hypertension, and Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.
de Meer
K
K
Kulik
W
W
Melissant
C F
CF
Rabelink
T J
TJ
Berger
R
R
Kaysen
G A
GA
D000328:Adult; D000596:Amino Acids / Q000378:metabolism; D001798:Blood Proteins / Q000652:urine; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D003404:Creatinine / Q000097:blood; D005260:Female; D045782:Hemiterpenes; D006801:Humans; D007262:Infusions, Intravenous; D007651:Keto Acids / Q000097:blood; D016014:Linear Models; D008099:Liver / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009401:Nephrosis / Q000652:urine*; D010084:Oxidation-Reduction; D010421:Pentanoic Acids / Q000097:blood; D014176:Protein Biosynthesis; D011507:Proteinuria / Q000652:urine*; D012709:Serum Albumin / Q000032:analysis; D017693:Sodium Bicarbonate; D014508:Urea / Q000097:blood / Q000652:urine; D014631:Valerates / Q000097:blood; D014633:Valine / Q000097:blood / Q000378:metabolism*
D000596:Amino Acids; D001798:Blood Proteins; D002247:Carbon Isotopes; D045782:Hemiterpenes; D007651:Keto Acids; D010421:Pentanoic Acids; D012709:Serum Albumin; D014631:Valerates; D002245:Carbon Dioxide; C001505:alpha-ketoisovalerate; D017693:Sodium Bicarbonate; D014508:Urea; D003404:Creatinine; D014633:Valine